Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Audentes Therapeutics (BOLD) Insider Trading & Ownership

Audentes Therapeutics logo

Audentes Therapeutics (NASDAQ:BOLD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.30%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$8.20 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get BOLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Audentes Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BOLD Insider Buying and Selling by Quarter

Audentes Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024Kristina BurowDirectorBuy200,000$16.00$3,200,000.00  
4/2/2024Ra Capital Management, L.P.Major ShareholderBuy312,500$16.00$5,000,000.00  
(Data available from 1/1/2013 forward)

BOLD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Audentes Therapeutics includes Kristina Burow, and Ra Capital Management, L.P.. Learn more on insiders at BOLD.

5.30% of Audentes Therapeutics stock is owned by insiders. Learn more on BOLD's insider holdings.

The following insiders have purchased BOLD shares in the last 24 months: Kristina Burow ($3,200,000.00), and Ra Capital Management, L.P. ($5,000,000.00).

Insiders have purchased a total of 512,500 BOLD shares in the last 24 months for a total of $8,200,000.00 bought.



This page (NASDAQ:BOLD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners